MedTrace Logo

Rapid Diagnostic Profiling of SARS-CoV-2 (COVID-19)

NCT04473365 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 838

Last updated 2023-12-20

No results posted yet for this study

Summary

The investigators will evaluate the profile of the immune response of Ethiopian population and examine its relationship with the noted low CD4+ T-cell count and underlying immune activation status among participants with COVID-19 and will compare results with those residing in Europe. In addition, this project will evaluate the performance of various rapid diagnostic tests (RDTs) for SARS-CoV-2, taking into account the above-determined immune system characteristics. We will also evaluate the effect of co-infection with parasites on COVID-19 severity

Conditions

Interventions

OTHER

Intestinal parasite

Pre-existing intestinal parasite infection present or absent at time of admission

Sponsors & Collaborators

  • Ethiopian Public Health Institute

    collaborator OTHER_GOV

  • Liverpool School of Tropical Medicine

    collaborator OTHER

  • Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

    collaborator OTHER

  • Tigray Health Research Institute

    collaborator UNKNOWN

  • Mekelle University

    lead OTHER

Principal Investigators

  • Dawit Wolday, MD, PhD · Mekelle University

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-20
Primary Completion
2022-06-30
Completion
2022-06-30

Countries

  • Ethiopia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04473365 on ClinicalTrials.gov